Breast Cancer-Clinical Trials
-
Phase 1 (phase I) trials study whether a new treatment is safe to use over a range of doses. The treatment may be given to people with different types of cancers.
-
A phase 1 trial is mainly a drug safety study.
-
Phase 2 (phase II) trials study how well a treatment works for certain cancer, such as breast cancer. These trials may include between 25 and 100 people.
-
After a drug (or other therapy) is found to be effective in treating breast cancer in a phase 2 trials, a phase 3 trial will study it further.
-
Phase 3 (phase III) trials study how well a new treatment (including surgical procedures) works compared to the standard treatment (standard of care).
-
Phase 4 (phase IV) trials study the long-term side effects of treatments or answer new questions about the treatment.
Related Conference of Breast Cancer-Clinical Trials
November 25-26, 2024
7th International Conference on Anti-Cancer Drugs & Therapies
Vancouver, Canada
April 21-22, 2025
16th International Conference on Cancer Stem Cell & Oncology Research
Amsterdam, Netherlands
Breast Cancer-Clinical Trials Conference Speakers
Recommended Sessions
- Abortion and Women Health
- Assisted Reproductive Technology (ART)
- Biology of Breast Cancer
- Breast Cancer and New Innovations in Treatment
- Breast Cancer on Pregnancy
- Breast Cancer Risk and Cause
- Breast Cancer Treatment
- Breast Cancer-Clinical Trials
- Breast Imaging Dosimetry
- Genetics of Breast Cancer
- Gynecology | Infectious Diseases | Oncology
- Rehabilitation of Breast Cancer
- Screening, Detecting and Diagnosing Breast Cancer
- Surgery in Breast Cancer
Related Journals
Are you interested in
- Advanced Oncology & Radiology Techniques - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Advanced Therapies in Cancer - CANCER THERAPY MEETING 2024 (France)
- Advancement in the Field of Cancer - CANCER THERAPY MEETING 2024 (France)
- Advancements in Oncology Nursing: Trends and Best Practicss - World Cancer 2025 (UK)
- Advancements in Tumor Microenvironment Targeting - Cancer Biology 2025 (UK)
- Advances in Cancer Biomarkers - Biomarkers Conference 2025 (Italy)
- Advances in Cancer Prevention and Risk Assessment - Preventive Oncology 2025 (Italy)
- Advances in Cancer Research and Treatment - Cancer Drugs 2024 (Canada)
- Advances in Cell-Based Drug Delivery Systems - Cancer Biology 2025 (UK)
- Advances in Supportive Care and Symptom Management - CANCER THERAPY MEETING 2024 (France)
- AI and Machine Learning in Cancer Care - CANCER2025 (Netherlands)
- Alternative Treatments and Therapeutics - Cancer Science 2024 (Italy)
- Anti-cancer Drug Discovery - CANCER THERAPY MEETING 2024 (France)
- Anti-Cancer Drug Discovery and Development - Cancer Drugs 2024 (Canada)
- Autophagy and Cancer Cell Survival Mechanisms - Cancer Biology 2025 (UK)
- Basic and Translational Research - ORAL CANCER SUMMIT 2025 (France)
- Bioinformatics and Biomarkers - Biomarkers Conference 2025 (Italy)
- Biomarker Detection Technologies - Biomarkers Conference 2025 (Italy)
- Biomarkers in Drug Development - Biomarkers Conference 2025 (Italy)
- Biopsy in Cancer Diagnosis: - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Breast Cancer - Cancer Science 2024 (Italy)
- Breast Cancer - Euro Cancer 2024 (Italy)
- Breast Cancer - Breast Cancer Summit 2025 (Italy)
- Breast Cancer and Cell Biology - Breast Cancer 2024 (France)
- Breast cancer and cell biology - Breast Cancer Summit 2025 (Italy)
- Breast Cancer And Immunology - Breast Cancer 2024 (France)
- Breast Cancer And Immunology - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Awareness - Breast Cancer 2024 (France)
- Breast Cancer Awareness - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Detection, Prevention and Diagnosis - Breast Cancer 2024 (France)
- Breast Cancer Detection, Prevention and Diagnosis - Breast Cancer Summit 2025 (Italy)
- Breast Cancer during pregnancy - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Management - Breast Cancer 2024 (France)
- Breast Cancer Nursing - Breast Cancer 2024 (France)
- Breast Cancer Nursing - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Radiation Therapy - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Risk - Breast Cancer 2024 (France)
- Breast Cancer Risk - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Staging - Breast Cancer 2024 (France)
- Breast Cancer Surgery - Breast Cancer 2024 (France)
- Breast cancer surgery - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Therapies - Breast Cancer Summit 2025 (Italy)
- Breast Cancer- Clinical Trails - Breast Cancer Summit 2025 (Italy)
- Breast Cancer-Clinical Trials - Breast Cancer 2024 (France)
- Breast Cancer: Screening, Diagnosis, and Treatment - CANCER2025 (Netherlands)
- Breast carcinoma/Breast cancer - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Cancer & Stem Cell Therapy - Euro Cancer 2024 (Italy)
- Cancer and its Relevance with other Diseases - Cancer Drugs 2024 (Canada)
- Cancer Biomarkers - Cancer Science 2024 (Italy)
- Cancer Biomarkers - Euro Cancer 2024 (Italy)
- Cancer Biomarkers & Bioinformatics - Cancer Drugs 2024 (Canada)
- Cancer Care in the Era of Digital Health - CANCER THERAPY MEETING 2024 (France)
- Cancer Case reports - Euro Cancer 2024 (Italy)
- Cancer Causes & Risk Factors - Cancer Drugs 2024 (Canada)
- Cancer Cell Signaling - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Cancer Control and Prevention - Cancer Science 2024 (Italy)
- Cancer Diagnosis - Euro Cancer 2024 (Italy)
- Cancer Diagnosis and Screening - Cancer Science 2024 (Italy)
- Cancer Diagnostics - World Cancer 2025 (UK)
- Cancer Diagnostics and Emerging Technologies - CANCER THERAPY MEETING 2024 (France)
- Cancer Drugs - Euro Cancer 2024 (Italy)
- Cancer Epidemiology - Cancer Drugs 2024 (Canada)
- Cancer Epidemiology - Euro Cancer 2024 (Italy)
- Cancer Epidemiology and Biomarkers - Preventive Oncology 2025 (Italy)
- Cancer Epidemiology and Public Health - World Cancer 2025 (UK)
- Cancer Epigenetics - Cancer Science 2024 (Italy)
- Cancer Genomics & Metabolomics - CANCER THERAPY MEETING 2024 (France)
- Cancer Genomics and Epigenetics - CANCER THERAPY MEETING 2024 (France)
- Cancer Genomics and Precision Oncology - Preventive Oncology 2025 (Italy)
- Cancer Health Disparities - CANCER THERAPY MEETING 2024 (France)
- Cancer Imaging - Euro Cancer 2024 (Italy)
- Cancer Immunology - CANCER THERAPY MEETING 2024 (France)
- Cancer Immunology & Immunotherapy - Cancer Drugs 2024 (Canada)
- Cancer Immunology & Immunotherapy - Euro Cancer 2024 (Italy)
- Cancer Immunology and Immunotherapy - World Cancer 2025 (UK)
- Cancer Immunology and Immunotherapy - Preventive Oncology 2025 (Italy)
- Cancer Metabolism - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Cancer Metabolism and Nutritional Interventions - CANCER2025 (Netherlands)
- Cancer Metastasis - Cancer Science 2024 (Italy)
- Cancer Nanotechnology - Cancer Drugs 2024 (Canada)
- Cancer Pathology & Genetics - Cancer Drugs 2024 (Canada)
- Cancer Personalized Medicine - Euro Cancer 2024 (Italy)
- Cancer Pharmacology - Cancer Drugs 2024 (Canada)
- Cancer Pharmacology - Euro Cancer 2024 (Italy)
- Cancer Prevention - Euro Cancer 2024 (Italy)
- Cancer Prevention and Early Detection - CANCER THERAPY MEETING 2024 (France)
- Cancer Prevention and Early Detection: The Nurse’s Role - World Cancer 2025 (UK)
- Cancer Prevention and Risk Reduction - CANCER2025 (Netherlands)
- Cancer Prevention Vaccines - Cancer Drugs 2024 (Canada)
- Cancer Research - Euro Cancer 2024 (Italy)
- Cancer Science - Cancer Science 2024 (Italy)
- Cancer screening - CANCER THERAPY MEETING 2024 (France)
- Cancer Stem Cells and Tumor Biology - CANCER2025 (Netherlands)
- Cancer Therapy - Cancer Science 2024 (Italy)
- Cancer Therapy - Euro Cancer 2024 (Italy)
- Cancer Treatment and Therapeutics - World Cancer 2025 (UK)
- Cancer Treatments - Euro Cancer 2024 (Italy)
- Cancer Vaccines - CANCER THERAPY MEETING 2024 (France)
- Cancer Vaccines and Personalized Immunization Strategies - Cancer Biology 2025 (UK)
- Cancer Vaccinology and Preventive Vaccines - CANCER2025 (Netherlands)
- Cancer: Lifestyle Connection and Nutrition - Euro Cancer 2024 (Italy)
- Cancers Pharmacology - Cancer Science 2024 (Italy)
- Cancers Pharmacology - Cancer Science 2024 (Italy)
- CAR-T Cell Therapy and Cell-Based Treatments - CANCER2025 (Netherlands)
- Carcinogenesis&Cancer Cell Biology - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Cardiovascular Biomarker Innovations - Biomarkers Conference 2025 (Italy)
- Case Studies - Breast Cancer 2024 (France)
- Case Studies - ORAL CANCER SUMMIT 2025 (France)
- Cell-Based Therapy - CANCER THERAPY MEETING 2024 (France)
- Cellular Mechanisms of Drug Resistance in Cancer - Cancer Biology 2025 (UK)
- Cellular Senescence and Tumor Suppression - Cancer Biology 2025 (UK)
- Cellular Therapies in Cancer Treatment - Cancer Biology 2025 (UK)
- Clinical and Medical Case Reports - Cancer Drugs 2024 (Canada)
- Clinical case studies and reports - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Clinical oncology& Radiation oncology - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Clinical Trials and Regulatory Aspects in Oncology - CANCER2025 (Netherlands)
- Clinical Trials and Research Innovations - World Cancer 2025 (UK)
- Collaboration and Networking in Cancer Research - CANCER THERAPY MEETING 2024 (France)
- CRISPR and Gene Editing in Cancer Therapy - Cancer Biology 2025 (UK)
- CRISPR/Cas9 in CSC Research - Cancer Stem Cells 2025 (Netherlands)
- CSC and Immunoediting - Cancer Stem Cells 2025 (Netherlands)
- CSC Biomarkers for Early Detection - Cancer Stem Cells 2025 (Netherlands)
- CSC Fate Determination and Differentiation - Cancer Stem Cells 2025 (Netherlands)
- CSC Heterogeneity in Tumors - Cancer Stem Cells 2025 (Netherlands)
- CSC Metabolism and Energy Pathways - Cancer Stem Cells 2025 (Netherlands)
- CSC Niche and Hypoxia - Cancer Stem Cells 2025 (Netherlands)
- CSC Plasticity and Tumor Progression - Cancer Stem Cells 2025 (Netherlands)
- CSC-Derived Exosomes and Communication - Cancer Stem Cells 2025 (Netherlands)
- CSC-Driven Angiogenesis - Cancer Stem Cells 2025 (Netherlands)
- CSC-Driven Resistance to Radiotherapy - Cancer Stem Cells 2025 (Netherlands)
- CSC-Mediated Immunosuppression - Cancer Stem Cells 2025 (Netherlands)
- CSCs and Tumor Microenvironment - Cancer Stem Cells 2025 (Netherlands)
- Diagnostic Imaging in Cancer: Innovations and Future Directions - Preventive Oncology 2025 (Italy)
- Diet and Lifestyle Effect on Breast Cancer - Breast Cancer 2024 (France)
- DNA Damage and Mutation - Cancer Drugs 2024 (Canada)
- Drug Resistance and Overcoming Challenges - CANCER THERAPY MEETING 2024 (France)
- Drug Resistance Mechanisms in CSCs - Cancer Stem Cells 2025 (Netherlands)
- Early Detection and Diagnostic - ORAL CANCER SUMMIT 2025 (France)
- Early Detection and Prevention - World Cancer 2025 (UK)
- Early Detection and Screening Innovations - CANCER2025 (Netherlands)
- Emerging Technologies in Cancer Research - World Cancer 2025 (UK)
- Environmental Biomarkers - Biomarkers Conference 2025 (Italy)
- Environmental Carcinogens and Cancer Epidemiology - CANCER2025 (Netherlands)
- Epidemiology - ORAL CANCER SUMMIT 2025 (France)
- Epidemiology of Breast Cancer and Risk Factors - Breast Cancer 2024 (France)
- Epidemiology of Breast Cancer and Risk Factors - Breast Cancer Summit 2025 (Italy)
- Epigenetic Biomarkers - Biomarkers Conference 2025 (Italy)
- Epigenetic Modifications and Cancer Treatment - Cancer Biology 2025 (UK)
- Epigenetics and CSC Regulation - Cancer Stem Cells 2025 (Netherlands)
- Ethical and Regulatory Issues in Cancer Research - CANCER THERAPY MEETING 2024 (France)
- Ethical Considerations in Cancer Research and Treatment - CANCER THERAPY MEETING 2024 (France)
- Ethics in Biomarker Research - Biomarkers Conference 2025 (Italy)
- Exosomes and Cell Communication in Cancer Therapy - Cancer Biology 2025 (UK)
- Future Directions in Cancer Therapy and Research - CANCER THERAPY MEETING 2024 (France)
- Future Directions in Oral Cancer Therapy - ORAL CANCER SUMMIT 2025 (France)
- Future Trends in Biomarker Research - Biomarkers Conference 2025 (Italy)
- Genetic and Environmental Factors in Cancer Development - Preventive Oncology 2025 (Italy)
- Genomic Biomarkers - Biomarkers Conference 2025 (Italy)
- Genomics and Cancer Epigenetics - CANCER2025 (Netherlands)
- Geriatric Oral Oncology - ORAL CANCER SUMMIT 2025 (France)
- Gynecologic Cancer Prevention and Control - CANCER THERAPY MEETING 2024 (France)
- Head and Neck Cancer - Euro Cancer 2024 (Italy)
- Hematology- Oncology - Cancer Science 2024 (Italy)
- Hematology- Oncology - Euro Cancer 2024 (Italy)
- Immunotherapy and Cancer Vaccines - CANCER2025 (Netherlands)
- Immunotherapy and CSCs - Cancer Stem Cells 2025 (Netherlands)
- Immunotherapy and Personalized Medicine in Oncology - Cancer Biology 2025 (UK)
- Infectious Disease Biomarkers - Biomarkers Conference 2025 (Italy)
- Inflammation and CSC Activation - Cancer Stem Cells 2025 (Netherlands)
- Inflammatory Breast Cancer - Breast Cancer 2024 (France)
- Inflammatory Breast Cancer - Breast Cancer Summit 2025 (Italy)
- Inflammatory Disease Biomarkers - Biomarkers Conference 2025 (Italy)
- Innovations in Cancer Data and Informatics - CANCER THERAPY MEETING 2024 (France)
- Innovations in Cancer Diagnostics and Early Detection - Preventive Oncology 2025 (Italy)
- Innovations in Cancer Education and Public Awareness - CANCER THERAPY MEETING 2024 (France)
- Innovative Approaches in Cancer Radiology - CANCER THERAPY MEETING 2024 (France)
- Innovative Treatment - ORAL CANCER SUMMIT 2025 (France)
- Integration of Patient-Reported Outcomes in Cancer therapy - CANCER THERAPY MEETING 2024 (France)
- Interventional radiology (IR) - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Leukemia/Blood cancer - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Liquid Biopsies for Precision Oncology - Cancer Biology 2025 (UK)
- Liquid Biopsies in Oncology - Biomarkers Conference 2025 (Italy)
- Liquid Biopsy and Non-Invasive Diagnostics - CANCER2025 (Netherlands)
- Lung Cancer - Euro Cancer 2024 (Italy)
- Male Breast Cancer Research - Breast Cancer 2024 (France)
- Male Breast Cancer Research - Breast Cancer Summit 2025 (Italy)
- Mammography - Breast Cancer 2024 (France)
- Managing Cancer Care & Patient Support - Cancer Drugs 2024 (Canada)
- Medications - ORAL CANCER SUMMIT 2025 (France)
- Metabolic Reprogramming in Cancer Cells - Cancer Biology 2025 (UK)
- Metastatic breast Cancer - Breast Cancer Summit 2025 (Italy)
- MicroRNA and Cancer - Cancer Drugs 2024 (Canada)
- Molecular and Genetic Insights in Oral Cancer - ORAL CANCER SUMMIT 2025 (France)
- Molecular Biology of Cancer - World Cancer 2025 (UK)
- Molecular Oncology: From Bench to Bedside - Preventive Oncology 2025 (Italy)
- Molecular Signaling in CSCs - Cancer Stem Cells 2025 (Netherlands)
- Monitoring Chronic Disease with Biomarkers - Biomarkers Conference 2025 (Italy)
- Nanotechnology and CSC Targeting - Cancer Stem Cells 2025 (Netherlands)
- Nanotechnology in Cancer Treatment - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Natural Products and CSC Targeting - Cancer Stem Cells 2025 (Netherlands)
- Neuro-Oncology - Euro Cancer 2024 (Italy)
- Neurodegenerative Disease Biomarkers - Biomarkers Conference 2025 (Italy)
- Novel Screening Methods for Early Detection - Preventive Oncology 2025 (Italy)
- Nursing Leadership and Professional Development in Oncology - World Cancer 2025 (UK)
- Nutrition, Lifestyle, and Cancer Prevention - Preventive Oncology 2025 (Italy)
- Oncogenomics - Cancer Science 2024 (Italy)
- Oncology - Euro Cancer 2024 (Italy)
- Oncology Nursing and Care - Cancer Science 2024 (Italy)
- Oncology Nursing and Patient Care - CANCER2025 (Netherlands)
- Oral Cavity Melanoma - ORAL CANCER SUMMIT 2025 (France)
- Organ Specific Cancer - Cancer Science 2024 (Italy)
- Organ Specific Cancer - Euro Cancer 2024 (Italy)
- Palliative Care and Quality of Life - CANCER2025 (Netherlands)
- Pediatric Biomarkers - Biomarkers Conference 2025 (Italy)
- Pediatric Oncology - Cancer Drugs 2024 (Canada)
- Pediatric Oncology - World Cancer 2025 (UK)
- Pediatric Oncology Innovations - CANCER2025 (Netherlands)
- Pediatric oral cancer - ORAL CANCER SUMMIT 2025 (France)
- Personalized Cancer Medicine and Targeted Therapy - Preventive Oncology 2025 (Italy)
- PET Scans in High-Risk Populations for Cancer Prevention - Preventive Oncology 2025 (Italy)
- Pharma-Oncology - CANCER THERAPY MEETING 2024 (France)
- Pharmacovigilance and Drug Safety in Oncology - CANCER2025 (Netherlands)
- Precision Medicine and Biomarkers - Biomarkers Conference 2025 (Italy)
- Precision Medicine and Personalized Therapies - CANCER THERAPY MEETING 2024 (France)
- Precision Oncology and Disparities (Implementation and Discovery) - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Precision Oncology and Personalized Medicine - CANCER2025 (Netherlands)
- Precision Oncology: Targeting Cancer at the Molecular Level - Cancer Biology 2025 (UK)
- Prevention Strategies - ORAL CANCER SUMMIT 2025 (France)
- Preventive Oncology in Low- and Middle-Income Countries - Preventive Oncology 2025 (Italy)
- Prostrate Cancer - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Proteomics in Biomarker Discovery - Biomarkers Conference 2025 (Italy)
- Psychiatric Biomarkers - Biomarkers Conference 2025 (Italy)
- Psychosocial Oncology and Mental Health - CANCER2025 (Netherlands)
- Psychotherapy and Cancer - CANCER THERAPY MEETING 2024 (France)
- Public Health Strategies in Reducing Cancer Burden - Preventive Oncology 2025 (Italy)
- Radiation Oncology - Cancer Science 2024 (Italy)
- Radiation Oncology - Euro Cancer 2024 (Italy)
- Radiation Oncology and Radiotherapy Advances - CANCER2025 (Netherlands)
- Radiation Therapy - Euro Cancer 2024 (Italy)
- Radiation Treatment - ORAL CANCER SUMMIT 2025 (France)
- Radiology - Breast Cancer 2024 (France)
- Radiology & Imaging Technologies - Cancer Drugs 2024 (Canada)
- Radiopharmaceuticals & Pharmacokinetics - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Rare Cancers and Orphan Drugs - CANCER2025 (Netherlands)
- Regenerative Medicines - Cancer Drugs 2024 (Canada)
- Rehabilitation - ORAL CANCER SUMMIT 2025 (France)
- RNA-based Therapies in Cancer - Cancer Biology 2025 (UK)
- Robotic Oncology - Cancer Drugs 2024 (Canada)
- Role of AI and Machine Learning in Cancer Diagnosis - Preventive Oncology 2025 (Italy)
- Role of AI in Cancer - Euro Cancer 2024 (Italy)
- Role of Artificial Intelligence in Precision Cancer Treatment - Cancer Biology 2025 (UK)
- Role of CSCs in Metastasis - Cancer Stem Cells 2025 (Netherlands)
- Role of EMT in CSC Plasticity - Cancer Stem Cells 2025 (Netherlands)
- Role of Microbiome in Cancer - CANCER THERAPY MEETING 2024 (France)
- Role of Nutrition in Oral Cancer Management - ORAL CANCER SUMMIT 2025 (France)
- Role of Organoids and 3D Cultures in Personalized Cancer Treatment - Cancer Biology 2025 (UK)
- Role of Stem Cells in Cancer Progression and Treatment - Cancer Biology 2025 (UK)
- Sarcoma - Euro Cancer 2024 (Italy)
- Skin Cancer - Cancer Science 2024 (Italy)
- Skin Cancer - Euro Cancer 2024 (Italy)
- Squamous cell carcinoma - ORAL CANCER SUMMIT 2025 (France)
- Stem Cell Therapy - Cancer Science 2024 (Italy)
- Stem Cell Transplantation (Bone Marrow Transplantation) - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Supportive Care and Palliative Medicine - World Cancer 2025 (UK)
- Surgical & Clinical Oncology - Cancer Drugs 2024 (Canada)
- Surgical Oncology - Cancer Science 2024 (Italy)
- Surgical Oncology and Minimally Invasive Techniques - CANCER2025 (Netherlands)
- Targeted Cancers Therapy - Cancer Science 2024 (Italy)
- Targeted Therapy and Molecular Diagnostics - CANCER2025 (Netherlands)
- Targeting Cancer Cell Cycle for Therapeutic Advances - Cancer Biology 2025 (UK)
- Targeting CSC Dormancy - Cancer Stem Cells 2025 (Netherlands)
- Targeting CSC-Specific Surface Markers - Cancer Stem Cells 2025 (Netherlands)
- Telemedicine and Digital Health in Oncology - CANCER2025 (Netherlands)
- Therapeutic Targeting of Cancer - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Therapy Resistance and CSCs - Cancer Stem Cells 2025 (Netherlands)
- Translational Biomarker Research - Biomarkers Conference 2025 (Italy)
- Translational Research and Clinical Applications - CANCER THERAPY MEETING 2024 (France)
- Treatment of Cancer - CANCER THERAPY MEETING 2024 (France)
- Tumor Biology - Cancer Science 2024 (Italy)
- Tumor Heterogeneity and Personalized Treatment Approaches - Cancer Biology 2025 (UK)
- Tumor Immunology - Cancer Science 2024 (Italy)
- Tumor Microenvironment and Its Role in Cancer Progression - Preventive Oncology 2025 (Italy)
- Tumor Microenvironment and Metastasis - CANCER2025 (Netherlands)
- Tumor virology - Cancer Science 2024 (Italy)
- Types of Cancer - Euro Cancer 2024 (Italy)
- Verrucous carcinoma - ORAL CANCER SUMMIT 2025 (France)